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Introduction: As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads across the 
globe, physicians face the challenges of a contagious pandemic including which patients to isolate, 
how to conserve personal protective equipment, and who to test. The current protocol at our hospital 
is to place anyone with new cough, dyspnea, or fever into airborne and contact precautions and 
consider them for testing. Unfortunately, the symptomatic presentations of coronavirus disease 2019 
(COVID-19) are proving more variable than previously thought. 
Case Report: Our case of COVID-19 presented with headache and then progressed to a meningitis-
like illness with co-existing shingles rash. 
Conclusion: COVID-19 can have a variety of initial presentations that are not the classic respiratory 
symptoms and fever. These presenting symptoms of COVID-19 can include a meningitis-like illness, 
as our case report indicates. The wide variety of presentations of COVID-19 may warrant widespread 
testing to identify cases, protect healthcare workers, and prevent the spread of this pandemic. [Clin 
Pract Cases Emerg Med. 2020;4(3):XXX–XXX.]
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INTRODUCTION
The year 2020 will forever be defined by the spread of 
severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2, previously 2019-nCoV), which causes coronavirus 
disease 2019 (COVID-19). COVID-19 can cause a devastating 
bilateral, multilobar pneumonia, acute respiratory distress 
syndrome, and death. The first identified cases appeared 
in Wuhan, China, in December 2019. The World Health 
Organization declared COVID-19 a public health emergency 
in February 2020, and the United States (US) currently has the 
highest burden of cases of any country.7
One of the highest priorities for patients and healthcare 
workers is identifying the presenting symptoms of COVID-19. 
Studies from China indicate that fever, cough, and dyspnea are 
among the most common presentations of the disease. Huang 
et al published one of the first prospective case studies of 41 
University of Massachusetts, Department of Emergency Medicine, 
Worcester, Massachusetts
patients in Wuhan and found that the most common symptoms 
were fever (98%) and cough (76%).3 The complete range of 
clinical manifestations included fever, non-productive cough, 
dyspnea, myalgia, and fatigue.3 
Here in the US, patients with “concerning symptoms” 
are placed in isolation. Our institution’s COVID-19 triage 
screening includes new cough, new shortness of breath, fever, 
recent travel, or known COVID-19 contacts. Initially, patients 
who screened positive for multiple risk factors were placed in 
a negative pressure room (if available) on airborne and contact 
precautions. However, as cases increased, the screening 
criteria expanded to patients who screened positive for any 
of the screening questions above. While these questions are 
consistent with the most common presenting symptoms, 
the range of clinical symptoms of this disease is varied 
and our screening questions are missing patients. This has 
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What do we already know about this clinical entity? 
Severe acute respiratory syndrome coronavirus 2 
(SARS-CoV2) which causes coronavirus disease 19 
(COVID-19) appeared in Wuhan, China in December, 
2019. It reportedly presents with shortness of breath, 
cough and fever.
What makes this presentation of disease reportable?
Our case report reviews a meningitis-like presentation 
of COVID-19 including symptoms of headache, 
meningismus and fever. Due to the unusual 
presentation, this patient had a delay in diagnosis.
What is the major learning point?  
COVID-19 presents with a more varied array of 
symptoms then previously identified which places 
patients at risk for delayed diagnosis and caregivers at 
risk of exposure. 
How might this improve emergency medicine practice? 
As our testing capability expands, all patients 
presenting to the emergency department should be 
placed on precautions and tested in order to improve 
diagnosis and prevent caregiver exposures.
clinical significance for both the patients, who have delayed 
diagnosis, as well as the healthcare providers who experience 
unprotected COVID-19 exposures. 
CASE REPORT
A 58-year-old-male with history of hyperlipidemia 
presented to the emergency department (ED) with the chief 
complaints of headache, abdominal pain, and constipation. 
The patient started having mid-to-lower abdominal discomfort 
associated with constipation two days prior to presentation. 
On the day of presentation, his discomfort worsened and 
he noted a fever of 100.7 degrees Fahrenheit (F). He also 
developed a progressively worsening headache located in 
bilateral occiputs and radiating to his neck. He denied a 
history of migraines. Patient denied international travel but 
had traveled to Florida the week prior. No cough, dyspnea, or 
known COVID-19 contacts were reported. 
Vital signs revealed a temporal temperature of 36.6º 
Celsius (C), heart rate 93 beats per minute (bpm), respiratory 
rate 18 breaths per minute, blood pressure 130/83 millimeters 
of mercury (mmHg), and oxygen saturation (SpO2) 98% 
on room air. He had clear lung sounds bilaterally, a normal 
cardiovascular exam, and mild tenderness in the right upper 
quadrant. He was also tender at the bilateral inserts of the 
suboccipital muscles. The patient was neurologically intact 
with a Glasgow Coma Scale of 15, normal cranial nerves, and 
no motor or sensory deficits. He had full range of motion of 
his neck and no meningismus. 
Laboratory results were remarkable for a normal white 
blood cell count of 5.3 x 103 microliters per liter (uL) (reference 
range 4.3-10.8 x103/uL) but with lymphopenia of 0.4 x103/uL 
(reference range 0.9-3.4 x103/uL). Lactic acid, basic metabolic 
panel, hepatic panel, and lipase were within normal limits. 
Computed tomography (CT) of the abdomen/pelvis showed no 
acute abnormality but did note minimal bibasilar atelectasis.
The patient’s headache initially improved with intravenous 
(IV) fluids and metoclopramide but later recurred. Due to the 
location of his headache and tenderness at the suboccipital muscle 
inserts, a bilateral occipital nerve block with 0.5% bupivacaine 
was performed with improvement of his pain. Shared decision-
making was conducted with the patient and a lumbar puncture 
(LP) was declined. He was discharged home with a diagnosis of 
non-specific viral syndrome and strict return precautions. 
Three days after his initial presentation, the patient continued 
to have fevers, headaches, and developed a dermatomal rash. He 
was started on famciclovir for presumed shingles. 
The patient re-presented to an affiliated ED six days after 
his initial presentation for fever, headache, neck pain, and diffuse 
abdominal pain. He also noted fatigue, myalgias, dyspnea, 
congestion, and rash. Vital signs revealed a temperature of 37.1º 
F, heart rate 94 bpm, respiration rate 16 breaths per minute, blood 
pressure 96/66 mmHg and SpO2 98% on room air. The physical 
exam was now more concerning for meningitis with neck rigidity 
and pain with neck movement. A vesicular rash along the right 
ninth and tenth thoracic dermatomes was also noted. The patient 
was otherwise neurologically intact and his pulmonary exam 
was normal. Due to the presence of the shingles rash, he was 
placed on strict airborne and contact precautions for concern of 
disseminated herpes zoster infection. 
An LP was performed due to concern for meningitis 
and the patient was started on IV acyclovir, vancomycin, 
and ceftriaxone. The LP revealed an opening pressure of 21 
centimeters of water (cm H2O) (normal range 10-20 cm H2O), 
elevated glucose of 84 milligrams per deciliter (mg/dL) (normal 
range 45-80 mg/dL or greater than 60% of serum glucose), 
elevated protein of 48 mg/dL (normal less than 45 mg/dl), 
and one white blood cell (WBC) in both tubes one and four 
(normal range 0-5 cells/microliter). Infectious disease consult 
later remarked that there was a low suspicion for meningitis 
based on his LP. A chest radiograph (CXR) showed subtle, 
patchy infiltrates in the lung bases (Image 1) suggesting early 
pneumonia, so the patient’s antibiotics were expanded to 
include IV doxycycline to cover atypical bacteria. 
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The patient was admitted to the general medicine floor 
for observation pending cerebrospinal fluid culture results. 
On day seven after his initial presentation, precautions 
were reduced from strict airborne to droplet and contact 
precautions. He symptomatically improved until the early 
morning of day eight after his initial presentation, when he 
started to complain of acute left-sided, pleuritic chest pain 
and shortness of breath. A rapid response was called. The 
patient was treated for possible acute coronary syndrome and 
further evaluated with a CXR and CT-pulmonary embolism 
protocol. Both the CXR (Image 1) and CT (Image 2) showed 
a multilobar peripheral pneumonia, which was highly 
concerning for COVID-19 infection.
Eight days after his initial presentation (day two of 
hospitalization), the patient was placed on strict airborne, 
contact, and droplet precautions. His respiratory status 
continued to deteriorate and he was transferred to the 
intensive care unit (ICU) on high-flow nasal cannula and 
required intubation later that day. His COVID-19 test via the 
Department of Public Health was presumptive positive. 
The patient was intubated in the ICU from day two of 
hospitalization until day 15. During his extensive ICU course, 
various treatments were trialed including lopinavir/ritonavir, 
a six-day course of hydroxycholorquine and azithromycin, 
as well as remdesivir starting hospital day 19. He was also 
continued on his course of antibiotics.
In a study from Wuhan the average time from onset 
of first symptoms to dyspnea was five days, to admission 
was seven days and to acute respiratory distress syndrome 
was eight days.4 This patient was admitted on day nine, 
decompensated on day 11 and was intubated for a total of  13 
days. The patient’s clinical course is summarized in Table 1.
Image 1. A) Portable chest radiograph on presentation to the 
emergency department, demonstrating subtle, patchy infiltrates 
visible in the lung bases suggesting early pneumonia (arrows). B) 
An anterior posterior chest radiograph two days after admission, 
demonstrating significant interval progression of peripherally 
located patchy opacities throughout both lungs (arrows) with 
areas of consolidation at the lung bases and right upper lobe.
Image 2. Computed tomography of the chest two days after 
admission demonstrating extensive, bilateral multifocal pneumonia 
most notable in the lower lobes (arrows).
DISCUSSION
This case draws to light the significant COVID-19 exposure 
risk to both the ED and medical floor staff. This patient had two 
ED visits as well as two days on the general medicine floor prior 
to initiation of full airborne and contact precautions due to his 
atypical symptoms on presentation.   
A literature review revealed that while the most common 
presenting symptoms are fever and cough, there is a dramatic 
range of symptoms, which can be associated with COVID-19. 
In a single-center, retrospective study of 54 healthcare workers 
Timeline Event
Day 1 Symptoms including abdominal pain, constipation 
start. Progresses to include headache, fever.
Day 3 Initial presentation with headache, fever, abdominal 
pain. Discharged from emergency department.
Day 9 Re-presents with headache, fever, and concern for 
meningitis. Undergoes lumbar puncture and admitted 
to general medicine for meningitis-like presentation. 
Day 11 Respiratory decompensation with evidence of 
bilateral multilobar pneumonia on chest radiograph 
and computed tomography of the chest.
Day 24 Extubated to nasal cannula in the intensive care 
unit, suffered from encephalopathy.
Day 27 Patient stable and transferred to the floor.
Day 32 Patient discharged home.
Table 1. Clinical course from onset of atypical symptoms until 
discharge of patient with presumptive coronavirus 19.
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Jiaojiao et al1 
(n =54)
Easom et al2 
(n=68)
Huang et al3 
(n=41)
Wang et al4 
(n=138)
Deng et al5 
(n = 225)
Guan et al6 
Meta-analysis (n=1099)
Fever 66.7% 40% 98% 98.6% 80.5% 43.8% (initial) 
88.6% (total)
Cough 31.5% 78% 76% 59.4% 37.7% 67.8%
Sputum production 5.6% 28% - 26.8% 21.7% 33.7%
Fatigue 6.7% - 44% includes 
myalgia
69.6% 25.3% includes 
myalgia
38.1%
Dyspnea 9.3% 25% 5% 31.2% 44% 18.7%
Chest pain/palpitations 7.4% 13% - - 10.6% -
Myalgia 5.6% 16% See fatigue 34.8% See fatigue 14.9%
Anorexia 5.6% - - 39.9% - -
Diarrhea - 13% 3% 10.1% 14.6% 3.8%
Headache - 4% 8% 6.5% 5.7% 13.6%
Sore throat - 1.9% - 17.4% - -
Hemoptysis - - 5% - 3.1% 0.9%
Nasal congestion 1.9% 29% - - - 4.8%
Table 2. Literature review of coronavirus 19 symptom presentation.
who succumbed to COVID-19 in Wuhan, fever was the most 
common presenting symptom followed by cough.1 Another 
retrospective study of 138 patients in Wuhan also confirmed that 
the most common presenting symptoms were fever, fatigue, and 
cough.4 However, both of these studies also showed significant 
prevalence of other symptoms such as myalgias, headache, 
nausea and diarrhea, which are typically not represented in 
our screening questions. Between 4-13% of patients presented 
with headache. Notably, no cases described a meningitis-like 
presentation as our patient specifically demonstrated. In addition, 
the New England Journal of Medicine published a meta-analysis 
of 1099 patients hospitalized across 552 sites as of January 
29, 2020. In terms of clinical symptoms on presentation, only 
43.8% of patients had fever on presentation but 88.7% developed 
fever during hospitalization. A fever was defined as axillary 
temperature of greater than 99.5º F (37.5º C). Cough was noted in 
67.8% and headache in 13.6% of patients. See Table 2 for a full 
table reviewing symptom prevalence in each of these studies.
Interestingly, Deng et al compared the presenting 
symptoms of patients with COVID-19 who progressed to severe 
respiratory illness vs those who remained mildly symptomatic. 
This retrospective study of 225 patients found statistically 
significant differences in the presenting clinical symptoms 
of these patients.5 Patients who presented with dyspnea, 
expectoration, low oxygen saturations, and severe illness were 
more likely to progress to death.5 In addition, the average day of 
admission for the group who recovered was day seven while the 
average day of admission for the group who died was day 10.5 
Patients who presented later in their clinical course appeared 
to progress to more severe illness.5 While our patient presented 
later and did progress to severe illness, he survived COVID-19 
and was extubated after 13 days. 
CONCLUSION
This case report adds to the current literature as there 
are no other current reports of meningitis-like presentation 
of COVID-19 or herpes zoster. We would also like to draw 
attention to the patient’s waxing and waning symptoms. 
As this virus spreads, patients are more likely to present 
with COVID-19. In addition, clinical studies from South 
Korea are concerning for an asymptomatic population of 
~30% of all virus carriers. The asymptomatic population 
as well as the varied presentations make a compelling 
argument for placing every ED patient under precautions 
on arrival. When and if widespread accurate testing 
is available, it would be prudent to be able to test all 
patients, especially those admitted to the hospital in order 
to decrease healthcare-related exposures. This paradigm 
would represent a shift in medicine as pre-test probability 
and testing based on symptoms is critical in our evaluation 
of patients. However, in a pandemic that is widespread and 
variable, a different tactic may be indicated. 
Documented patient informed consent al has been obtained and 
filed for publication of this case report.
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